Carly P. Smith, PhD and Daniel R. George, PhD, MSc
Invisibility of racial inequity and gender inclusion in clinical research means key features of disease etiology and symptom presentation are unaccounted for.
AMA J Ethics. 2021;23(7):E563-568. doi:
10.1001/amajethics.2021.563.
Changes made in 2017 to the World Medical Association Physician’s Pledge strive to keep in step with geopolitical trends by addressing patient autonomy and collegiality.
AMA J Ethics. 2019;21(9):E796-800. doi:
10.1001/amajethics.2019.796.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.
John Timothy Kayiwa, MSc, Benard Matovu, MS, Michael Mutebi, Charity Angella Nassuna, MSc, Leonara Nabatanzi, Kevin T. Castle, DVM, MS, Robert M. Kityo, PhD, MS, and Rebekah C. Kading, PhD, MS
Bats are diverse mammals, globally distributed and ecologically critical, yet some carry disease agents that have severe consequences for human health.
AMA J Ethics. 2024;26(2):E153-161. doi:
10.1001/amajethics.2024.153.
A digital record of place history and environmental context can provide a piece of clinically relevant information to help physicians understand what toxins patients may have been exposed to.